摘要 |
<p>The present invention relates to A compound of formula (I) wherein A, U, V, X, Z, R?1, Y, R2 and R3¿ are defined in the description or a physiologically acceptable salt, solvate or derivative thereof, to compositions and processes for making said compounds and their use in treating conditions ameliorated by an apoB-100 and/or MTP inhibitor.</p> |